<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:57:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10424155" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10424155</identifier>
        <datestamp>2023-08-15</datestamp>
        <setSpec>tvst</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Transl Vis Sci Technol</journal-id>
              <journal-id journal-id-type="iso-abbrev">Transl Vis Sci Technol</journal-id>
              <journal-id journal-id-type="publisher-id">TVST</journal-id>
              <journal-title-group>
                <journal-title>Translational Vision Science &amp; Technology</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2164-2591</issn>
              <publisher>
                <publisher-name>The Association for Research in Vision and Ophthalmology</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10424155</article-id>
              <article-id pub-id-type="pmcid">PMC10424155</article-id>
              <article-id pub-id-type="pmc-uid">10424155</article-id>
              <article-id pub-id-type="pmid">37555738</article-id>
              <article-id pub-id-type="pmid">37555738</article-id>
              <article-id pub-id-type="doi">10.1167/tvst.12.8.5</article-id>
              <article-id pub-id-type="publisher-id">TVST-23-5711</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Clinical Trials</subject>
                </subj-group>
                <subj-group subj-group-type="category">
                  <subject>Clinical Trials</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of Carboxymethylcellulose Artificial Tears on Ocular Surface Microbiome Diversity and Composition, A Randomized Controlled Trial</article-title>
                <alt-title alt-title-type="runhead">Effects of Carboxymethylcellulose on the Eye Microbiome</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Zhou</surname>
                    <given-names>Yujia</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sidhu</surname>
                    <given-names>Gurjit S.</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Whitlock</surname>
                    <given-names>Joan A.</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Abdelmalik</surname>
                    <given-names>Bishoy</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mayer</surname>
                    <given-names>Zachary</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Youlei</given-names>
                  </name>
                  <xref rid="aff3" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Gary P.</given-names>
                  </name>
                  <xref rid="aff2" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Steigleman</surname>
                    <given-names>Walter A.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <aff id="aff1"><label>1</label>Department of Ophthalmology, University of Florida Shands Hospital, Gainesville, FL, USA</aff>
                <aff id="aff2"><label>2</label>Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA</aff>
                <aff id="aff3"><label>3</label>University of Florida College of Medicine, Gainesville, FL, USA</aff>
              </contrib-group>
              <author-notes>
                <corresp id="cor1"><label>*</label><bold>Correspondence:</bold> Yujia Zhou, 185 Crescent St. Apt 30-2 Waltham, MA 02453, USA. e-mail: <email>yzhou1618@gmail.com</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>09</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue>8</issue>
              <elocation-id>5</elocation-id>
              <history>
                <date date-type="accepted">
                  <day>16</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
                <date date-type="received">
                  <day>24</day>
                  <month>4</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright 2023 The Authors</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This work is licensed under a Creative Commons Attribution 4.0 International License.</license-p>
                </license>
              </permissions>
              <self-uri xlink:title="pdf" xlink:href="tvst-12-8-5.pdf"/>
              <abstract>
                <sec>
                  <title>Purpose</title>
                  <p>Carboxymethylcellulose is an artificial tear ingredient known to decrease gut microbiome diversity when ingested. This study examines the effect of carboxymethylcellulose on ocular surface microbiome diversity and composition.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p>Healthy adult participants without significant ophthalmic disease or concurrent carboxymethylcellulose artificial tear use were allocated randomly to take carboxymethylcellulose or control polyethylene glycol artificial tears for seven days. Conjunctival swabs were collected before and after artificial tear treatment. This trial is registered at clinicaltrials.gov (NCT05292755). Primary outcomes included abundance of bacterial taxa and microbiome diversity as measured by the Chao-1 richness estimate, Shannon's phylogenetic diversity index, and UniFrac analysis. Secondary outcomes included Ocular Surface Disease Index scores and artificial tear compliance.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p>Of the 80 enrolled participants, 66 completed the trial. Neither intervention affected Chao-1 richness (analysis of variance [ANOVA], <italic toggle="yes">P</italic> = 0.231) or Shannon's diversity index (ANOVA, <italic toggle="yes">P</italic> = 0.224). Microbiome samples did not separate by time point (permutation multivariate analysis of variance [PERMANOVA], <italic toggle="yes">P</italic> = 0.223) or intervention group (PERMANOVA, <italic toggle="yes">P</italic> = 0.668). LEfSe taxonomic analysis revealed that carboxymethylcellulose depleted several taxa including <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Lachnoclostridium</italic>, but enriched <italic toggle="yes">Enterobacteriaceae</italic>, <italic toggle="yes">Citrobacter</italic>, and <italic toggle="yes">Gordonia</italic>. Both interventions decreased OSDI scores (Wilcoxon signed rank test, <italic toggle="yes">P</italic> &lt; 0.05), but there was no significant difference between interventions (Mann-Whitney <italic toggle="yes">U</italic>, <italic toggle="yes">P</italic> = 0.54).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p>Carboxymethylcellulose artificial tears increased <italic toggle="yes">Actinobacteriota</italic> but decreased <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Firmicutes</italic> bacteria. Carboxymethylcellulose artificial tears do not affect ocular surface microbiome diversity and are not significantly more effective than polyethylene glycol artificial tears for dry eye treatment.</p>
                </sec>
                <sec>
                  <title>Translational Relevance</title>
                  <p>The 16S microbiome analysis has revealed small changes in the ocular surface microbiome associated with artificial tear use.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>microbiome</kwd>
                <kwd>bacterial</kwd>
                <kwd>dry eye</kwd>
                <kwd>artificial tear</kwd>
                <kwd>infection</kwd>
              </kwd-group>
              <counts>
                <page-count count="14"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1">
              <title>Introduction</title>
              <p>Dry eye syndrome (DES) is a disorder of the ocular surface, frequently characterized by lipid or aqueous deficiency of the tear film.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Associated symptoms such as stinging, burning, itching, light sensitivity, and blurry vision may reduce patient quality of life and productivity.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> In chronic cases, the ocular surface including the tear film, cornea, and conjunctiva may develop lasting structural damage.<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> Mounting evidence now suggests that the disorder is multifactorial, involving neurotrophic deficiency, meibomian gland dysfunction, and inflammation. Antigen-presenting cells and T helper 17 cells on the ocular surface may mediate ocular surface inflammation.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Indeed, several immunomodulatory therapeutics are effective treatments for DES, although factors inciting inflammation in DES are not definitive.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref></p>
              <p>One potential factor mediating the inflammatory pathophysiology of DES is the ocular surface microbiome (OSM), composed of all microbial flora colonizing the ocular surface.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> In the human OSM, <italic toggle="yes">Corynebacterium, Staphylococcus, Streptococcus, Propionibacterium, Pseudomonas,</italic> and <italic toggle="yes">Acinetobacter</italic> are the primary bacterial genera.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>–</sup><xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> Fungal and viral genera include the fungi <italic toggle="yes">Aspergillus</italic>, <italic toggle="yes">Malassezia</italic>, <italic toggle="yes">Setosphaeria</italic>, and <italic toggle="yes">Haematonectria</italic>, as well as the viruses <italic toggle="yes">human</italic>
<italic toggle="yes">papilloma</italic>
<italic toggle="yes">virus</italic> and <italic toggle="yes">Torque</italic>
<italic toggle="yes">teno</italic>
<italic toggle="yes">virus</italic>.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref><sup>–</sup><xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> Environmental factors and ocular diseases are related to OSM composition. For example, sex and ethnicity have not been associated with unique OSM features,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> whereas age, climate, and contact lens use are associated with changes in the OSM composition.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>–</sup><xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> It is therefore unsurprising that DES has been associated with increased microbial diversity and changes in species abundance.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref></p>
              <p>Artificial tears (ATs) are a mainstay of DES therapy.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> Formulations attempt to match the properties of endogenous tears and are produced with or without a preservative.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> They typically contain electrolytes and a thickener such as carboxymethylcellulose (CMC), hyaluronic acid, or polyethylene glycol (PEG). The thickener is crucial to AT retention on the ocular surface, as endogenous tears have higher viscosity than saline solution, which allows the tear film to resist washout from shear forces during blinks.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Ingested CMC, however, has been shown to cause decreased gut microbiome diversity and modified abundance of bacterial genera such as <italic toggle="yes">Faecalibacterium</italic>, <italic toggle="yes">Ruminococcus</italic>, <italic toggle="yes">Roseburia</italic><italic toggle="yes">,</italic> and <italic toggle="yes">Lachnospiraceae</italic>.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> Animal studies also suggest that these changes may result in clinically significant immunologic changes.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Studies on the eyelid microbiome and OSM have shown that prostaglandin analogues increase beta diversity, topical anesthetics have been shown to decrease <italic toggle="yes">Cutibacterium</italic> species, and sodium hyaluronate have been shown to decrease abundance of specific bacterial species such as <italic toggle="yes">Flavobacterium caeni</italic> and <italic toggle="yes">Deinococcus antarcticus</italic>.<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref><sup>–</sup><xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> It therefore stands to reason that CMC-ATs may also have measurable effects on the OSM.</p>
              <p>Given the widespread use of CMC-ATs and its potential implications for the OSM, we conducted a double-masked randomized controlled trial examining the effects of CMC-ATs on the OSM and DES symptoms, compared to a control PEG-AT without CMC. Outcomes included metagenomic analysis of the OSM by 16S bacterial ribosomal RNA (rRNA) sequencing,<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> subjective DES symptoms scored using the Ocular Surface Disease Index (OSDI) survey,<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref><sup>,</sup><xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> and AT compliance surveys.</p>
            </sec>
            <sec sec-type="methods" id="sec2">
              <title>Methods</title>
              <sec id="sec2-1">
                <title>Patients and Study Design</title>
                <p>This is a double-masked randomized controlled trial (<xref rid="fig1" ref-type="fig">Fig. 1</xref>) conducted at the University of Florida Oaks Eye Center from April 2022 to May 2022. Adults aged 18 years or older with the ability to self-administer preservative-free ATs were eligible for enrollment. Adults with active eye infections, ocular prostheses, autoimmune diseases, cancers of the eye, or history of CMC-AT use, immunomodulatory therapy, steroids, antibiotics, preserved eyedrops, and medicated eyedrops within one week of study enrollment were excluded. The trial was conducted in compliance with the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. Institutional review board approval was obtained at the University of Florida, and informed consent was obtained from each patient before data collection. The trial is registered at <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT05292755" ext-link-type="uri">https://clinicaltrials.gov/ct2/show/NCT05292755</ext-link>.</p>
                <fig position="float" id="fig1">
                  <label>Figure 1.</label>
                  <caption>
                    <p>Study design and participant flow chart. After 96 prospective participants were assessed for eligibility, 80 participants were enrolled. Patients were assigned by simple randomization to receive either CMC or PEG ATs, masked to the participant and the researcher. Conjunctival swabs and surveys were administered on days 1 and 7. Participant dropout was five for the CMC group and nine for the PEG group.</p>
                  </caption>
                  <graphic xlink:href="tvst-12-8-5-f001" position="float"/>
                </fig>
              </sec>
              <sec id="sec2-2">
                <title>Intervention and Outcomes</title>
                <p>Enrolled participants were randomized to receive either ATs containing 0.5% CMC (Refresh Plus; Allergan Inc., Dublin, Ireland) or control ATs containing 0.4% PEG (Systane PF; Alcon Labs, Fort Worth, TX, USA). For the purposes of masking, one researcher with no participant contact (Li, Y.) created 80 identical boxes, each labeled with a unique alphanumeric code. Boxes contained 30 similar, unlabeled, and transparent vials of either CMC (n = 40) or PEG (n = 40) ATs. Each alphanumeric code and its contents were recorded on a spreadsheet (Excel 2016; Microsoft, Redmond, WA, USA) and randomly paired with a numerical code (1–80) using a computer algorithm. Required sample size was calculated by power estimates in IBM SPSS 28 (IBM Corp., Armonk, NY, USA) with anticipated 20% participant dropout. The spreadsheet with listed interventions was not accessible to other researchers until completion of the protocol. Enrolled participants received boxes 1 to 80 in order of enrollment and used the alphanumeric box codes for identification. Participants were asked to instill one drop of the given AT in both eyes three times daily for seven days, spaced evenly throughout the day, and to return for follow-up on the seventh day. PEG-ATs were chosen as the control because of their similar physical properties and vial appearance, because saline solution has a noticeably lower viscosity than CMC-ATs.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Manufacturer markings were removed from all vials.</p>
                <p>Primary outcomes included alpha diversity, beta diversity, and relative abundance of bacterial genera derived from pooled conjunctival swabs at days 1 and 7 for each participant. Secondary outcomes included the OSDI survey and compliance scores, collected from a computerized survey. Compliance scores were self-reported by participants as the estimated number of AT drops used in each eye daily, with ideal scores at one drops per eye daily although participants may have used more or fewer drops. The OSDI is a validated survey for assessing subjective dry eye symptomatology and quality of life, ranging from a score of 0 indicating no symptoms up to 48 indicating severe symptoms.</p>
              </sec>
              <sec id="sec2-3">
                <title>Ocular Surface Microbiome Sample Collection and Processing</title>
                <p>Before each conjunctival swab, one drop of proparacaine was instilled in both eyes. A sterile solid-core nylon swab (DNA/RNA Shield Swab collection kit; Zymo, Orange, CA, USA) was rotated in the inferior fornix of the left eye, then the right eye, and placed into a bead-beating tube containing 750 µL DNeasy lysis buffer (DNeasy PowerSoil Pro DNA extraction kit; Qiagen, Hilden, Germany) and stored at 4°C until further processing. Several blank swabs with the same proparacaine, swabs, and tubes were performed in room air without a participant present as controls.</p>
                <p>Genomic DNA was extracted using the DNeasy PowerSoil Pro DNA extraction kit according to the manufacturer's instructions. For each sample, the V1-V3 hypervariable region of the 16S rRNA gene was amplified using primers 27F (5ʹ AGAGTTTGATCCTGGCTCAG 3ʹ) and 534R (5ʹ ATTACCGCGGCTGCTGG 3ʹ) with barcodes to allow multiplex deep sequencing as described previously.<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Each 20 µL polymerase chain reaction (PCR) mixture contained 2 µL of extracted DNA, 100 nM of the forward primer, 100 nM of the reverse primer, and 0.15 µL of Accuprime Taq High Fidelity Polymerase, 2 µl 10X PCR buffer II (Invitrogen, Carlsbad, CA, USA). Cycling conditions were as follows: denaturation at 95°C for two minutes, 25 cycles of denaturation at 95°C for 20 seconds, annealing at 56°C for 30 seconds and extension at 72°C for five minutes. PCR products were analyzed on 1% SYBR Safe agarose gel. Gel slices containing the amplicons were extracted and purified using the NucleoSpin Gel and PCR Clean-up kit (Machery-Nagel, Bethelhem, PA, USA). Purified PCR products were quantified using the Qubit HS DNA quantification kit (Invitrogen) and pooled in equimolar concentration. Quantitative PCR was used to quantify the concentration of the pooled PCR products using Library Quant Kit (Kapa Biosystems, Wilmington, MA, USA). The use of barcodes allowed multiplexing and bidirectional sequencing on the Illumina MiSeq platform (Illumina, San Diego, CA, USA).</p>
              </sec>
              <sec id="sec2-4">
                <title>Data Processing and Statistical Analysis</title>
                <p>Raw MiSeq reads (covering the V1–V3 hypervariable region of the 16S rRNA gene using primers 27F and 534R) were demultiplexed using cutadapt4.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> Demultiplexed reads were imported into Qiime2 v2021.11 and denoised by dada2 pipeline in qiime2.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> Taxonomy was assigned using the silva 138 SSU nr99 dataset and classify-sklearn.qiime, and the phylogeny plugin was used to generate unrooted and rooted trees. Taxa with greater than 10 reads identified in any negative control swabs were excluded from analysis and negative controls were compared to samples by UniFrac analysis. Qiime2 diversity plugin was used to perform core metrics analysis, alpha-group significance, and beta-group significance at the level of amplicon sequence variants (ASVs) with a 95% confidence interval. Classical statistics including analysis of variance (ANOVA), permutation multivariate analysis of variance (PERMANOVA), and Mann-Whitney tests were validated in SPSS at the same 95% confidence interval for the appropriate data type. Comparisons between timepoints were performed with pairwise assumptions. LEfSe analysis was performed at <ext-link xlink:href="https://huttenhower.sph.harvard.edu/galaxy/" ext-link-type="uri">https://huttenhower.sph.harvard.edu/galaxy/</ext-link>.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref></p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3">
              <title>Results</title>
              <p>Among the 80 participants enrolled, 35 participants in the CMC group completed the follow-up period, and 31 participants in the PEG group completed the follow-up period. No intervention-associated complications were observed, and both interventions were well tolerated. Participant characteristics are displayed in the <xref rid="tbl1" ref-type="table">Table</xref>. Most participants were female (70%), did not wear contact lenses (77%), and had no history of ocular surgery (74%). Between-group analyses did not show any significant differences in participant characteristics. Among the participants who were enrolled and randomized (N = 80), 14 participants dropped out from the study either by not completing the survey upon follow-up, or by missing the follow-up visit altogether. Two participants later volunteered scheduling conflicts as the cause of dropout, whereas the remaining participants could not be reached. Participant dropout rates were also not significantly different between study arms (<xref rid="fig1" ref-type="fig">Fig. 1</xref>) by χ<sup>2</sup> test (<italic toggle="yes">P</italic> = 0.239). Similar compliance was reported in both arms of the study, because most participants reported using two or three drops of ATs after being instructed to use three drops daily in both eyes. One participant in the CMC arm and two participants in the PEG arm, however, reported using no drops. Two participants in the CMC arm also reported using an average of five drops daily.</p>
              <table-wrap position="float" content-type="4col" id="tbl1">
                <label>Table.</label>
                <caption>
                  <p>Participant Characteristics</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <colgroup span="1">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="char" char="." span="1"/>
                  </colgroup>
                  <thead>
                    <tr>
                      <th rowspan="1" colspan="1"/>
                      <th align="center" colspan="2" rowspan="1">Intervention Group</th>
                      <th rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <th rowspan="1" colspan="1">Characteristic</th>
                      <th rowspan="1" colspan="1">CMC</th>
                      <th rowspan="1" colspan="1">PEG</th>
                      <th align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> Value (Statistic)</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td rowspan="1" colspan="1">Age, mean (SD)</td>
                      <td rowspan="1" colspan="1">41.2 (17.8)</td>
                      <td rowspan="1" colspan="1">40.0 (13.4)</td>
                      <td rowspan="1" colspan="1">0.760 (<italic toggle="yes">t</italic>)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Sex</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1">0.256 (χ<sup>2</sup>)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Male</td>
                      <td rowspan="1" colspan="1">12</td>
                      <td rowspan="1" colspan="1">8</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Female</td>
                      <td rowspan="1" colspan="1">23</td>
                      <td rowspan="1" colspan="1">23</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Contact Lens Use</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1">0.979 (χ<sup>2</sup>)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Yes</td>
                      <td rowspan="1" colspan="1">8</td>
                      <td rowspan="1" colspan="1">7</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> No</td>
                      <td rowspan="1" colspan="1">27</td>
                      <td rowspan="1" colspan="1">24</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Ocular surgical history</td>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1"/>
                      <td rowspan="1" colspan="1">0.454 (χ<sup>2</sup>)</td>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> Yes</td>
                      <td rowspan="1" colspan="1">7</td>
                      <td rowspan="1" colspan="1">10</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1"> No</td>
                      <td rowspan="1" colspan="1">28</td>
                      <td rowspan="1" colspan="1">21</td>
                      <td rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td rowspan="1" colspan="1">Compliance (drops), mean (SD)</td>
                      <td rowspan="1" colspan="1">2.86 (0.81)</td>
                      <td rowspan="1" colspan="1">2.16 (0.82)</td>
                      <td rowspan="1" colspan="1">0.139 (U)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="tb1fn1">
                    <p>Participant characteristics were not significantly different between treatment groups at a 95% confidence threshold using statistical tests indicated (<italic toggle="yes">t</italic>, independent-samples; χ<sup>2</sup>, χ<sup>2</sup> test of homogeneity; U, Mann-Whitney U).</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>At baseline, the mean (standard deviation [SD]) OSDI scores were 7.69 (9.35) for the CMC group and 5.71 (7.70) for the PEG group. After intervention, the mean (SD) OSDI scores were 4.77 (7.93) for the CMC group and 3.35 (4.56) for the PEG group. This constituted a mean ΔOSDI (SD) of −2.91 (4.43) for the CMC group and −2.35 (5.42) for the PEG group. Both interventions were associated with a significant reduction in OSDI scores by pairwise Wilcoxon signed rank test (<xref rid="fig2" ref-type="fig">Fig. 2</xref>a, Z<sub>CMC</sub> = −3.549, <italic toggle="yes">P</italic><sub>CMC</sub> &lt; 0.01, Z<sub>PEG</sub> = −2.390, <italic toggle="yes">P</italic><sub>PEG</sub> = 0.02), but there was no significant difference in ΔOSDI between interventions by Mann-Whitney U test (<xref rid="fig2" ref-type="fig">Fig. 2</xref>b, <italic toggle="yes">U</italic> = 590, <italic toggle="yes">P</italic> = 0.54).</p>
              <fig position="float" id="fig2">
                <label>Figure 2.</label>
                <caption>
                  <p>Box plots of ocular surface disease index scores. Outliers are shown as circles, and extreme outliers are shown as asterisks. (a) Ocular surface disease index scores are significantly lower after either CMC or PEG interventions. (b) There was no significant difference in reduction of ocular surface disease index scores between groups.</p>
                </caption>
                <graphic xlink:href="tvst-12-8-5-f002" position="float"/>
              </fig>
              <p>Sequencing generated a maximum of 590 ASVs. The total number of reads from all participant samples and controls was 8,894,613 and was reduced to 4,554,231 after filtering and denoising. After contaminant filtering, 490 ASVs remained for analysis and were classified into 12 phyla (<xref rid="fig3" ref-type="fig">Fig. 3</xref>a), 18 classes (<xref rid="fig3" ref-type="fig">Fig. 3</xref>b), 53 orders, 100 families, and 236 genera. Beta diversity analysis (<xref rid="fig3" ref-type="fig">Figs. 3</xref>c, <xref rid="fig3" ref-type="fig">3</xref>d) revealed grouping of controls. Species richness as measured by the Chao-1 estimate is displayed in <xref rid="fig4" ref-type="fig">Figure 4</xref>a. Between-group analyses showed no significant difference in richness between the CMC group and PEG group at any time and showed no change in richness after either intervention (ANOVA, <italic toggle="yes">P</italic> = 0.231). Species diversity as measured by the Shannon index are displayed in <xref rid="fig4" ref-type="fig">Figure 4</xref>b. Between-group analyses showed no significant difference in diversity between the CMC group and PEG group at any time and showed no change in diversity after either intervention (ANOVA, <italic toggle="yes">P</italic> = 0.224). Overall, neither intervention changed alpha diversity.</p>
              <fig position="float" id="fig3">
                <label>Figure 3.</label>
                <caption>
                  <p>Next-Generation Sequencing Results. Taxonomic classification summary for all unfiltered samples at the (a) phylum and (b) class level. Sample letters indicate participant and numbers indicate before or after intervention. Asterisks indicate no classification available at this taxonomic level. (c) Principal coordinate analysis of unweighted UniFrac distances showing negative control samples have a distinct grouping within unfiltered sample microbiomes. (d) Principal coordinate analysis of weighted UniFrac distances showing negative control samples have a distinct grouping within unfiltered sample microbiomes.</p>
                </caption>
                <graphic xlink:href="tvst-12-8-5-f003" position="float"/>
              </fig>
              <fig position="float" id="fig4">
                <label>Figure 4.</label>
                <caption>
                  <p>Box plots of alpha diversity. Alpha diversity measures are displayed for samples collected from both intervention groups at days 1 and 7. Outliers are shown as circles, and extreme outliers are shown as asterisks. (a) Species richness is not significantly different between groups at any time point. (b) Species diversity is not significantly different between groups at any time point.</p>
                </caption>
                <graphic xlink:href="tvst-12-8-5-f004" position="float"/>
              </fig>
              <p>Differences in the microbial community structure were compared using UniFrac. Mann-Whitney repeated-measure comparisons of unweighted UniFrac distances (<italic toggle="yes">U</italic> = 448, <italic toggle="yes">P</italic> = 0.227) and weighted UniFrac distances (<italic toggle="yes">U</italic> = 540, <italic toggle="yes">P</italic> = 0.9795) did not show any significant between-group differences (<xref rid="fig5" ref-type="fig">Figs. 5</xref>a, <xref rid="fig5" ref-type="fig">5</xref>b). Samples did not separate by time point (PERMANOVA, <italic toggle="yes">P</italic> = 0.223) or intervention group (PERMANOVA, <italic toggle="yes">P</italic> = 0.668). However, separation was observed among samples along the first principal coordinate axis in unweighted UniFrac (<xref rid="fig5" ref-type="fig">Fig. 5</xref>c), but not in weighted UniFrac (<xref rid="fig5" ref-type="fig">Fig. 5</xref>d). Interestingly, samples clustered significantly by participant sex (PERMANOVA, <italic toggle="yes">P</italic> = 0.002) in unweighted UniFrac analysis (<xref rid="fig5" ref-type="fig">Fig. 5</xref>e), but this clustering was not observed in weighted UniFrac analysis (<xref rid="fig5" ref-type="fig">Fig. 5</xref>f). Although the overall microbiome community structures were not significantly altered by AT treatment, the relative abundance of several taxa was significantly changed by the treatments. <xref rid="fig6" ref-type="fig">Figure 6</xref>a shows the 10 most abundant bacterial genera from all OSM samples. LEfSe taxonomic analysis revealed that CMC treatment depleted several taxa including <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Lachnoclostridium</italic>, and enriched <italic toggle="yes">Enterobacteriaceae</italic>, <italic toggle="yes">Citrobacter</italic>, and <italic toggle="yes">Gordonia</italic> (<xref rid="fig6" ref-type="fig">Fig. 6</xref>b). PEG treatment depleted <italic toggle="yes">Anaerostipes</italic> and enriched <italic toggle="yes">Tyzzerella</italic>, <italic toggle="yes">Brevundimonas</italic>, and <italic toggle="yes">Sphingomonas</italic> (<xref rid="fig6" ref-type="fig">Fig. 6</xref>c).</p>
              <fig position="float" id="fig5">
                <label>Figure 5.</label>
                <caption>
                  <p>Beta diversity analysis. (a) Box plot of pairwise unweighted Unifrac distances between day 1 and day 7 time points, showing no significant differences between the two intervention groups. (b) Box plot of pairwise weighted UniFrac distances between day 1 and day 7 time points, showing no significant differences between the two intervention groups. (c) Principal coordinate analysis of unweighted UniFrac distances showing no significant grouping by intervention or time point. (d) Principal coordinate analysis of weighted UniFrac distances showing no significant grouping by intervention or time point. (e) Principal coordinate analysis of unweighted UniFrac distances shows grouping by participant sex. (f) Principal coordinate analysis of weighted UniFrac distances shows no significant grouping by participant sex.</p>
                </caption>
                <graphic xlink:href="tvst-12-8-5-f005" position="float"/>
              </fig>
              <fig position="float" id="fig6">
                <label>Figure 6.</label>
                <caption>
                  <p>Bacterial relative abundance. (a) Bar graph of the top 10 most abundant bacterial genera from all ocular surface microbiome samples, with mean relative abundances listed. (b) LEfSe taxonomic analysis of taxa before and after CMC AT treatment at the genus level. (c) LEfSe taxonomic analysis of species before and after PEG AT treatment at the genus level.</p>
                </caption>
                <graphic xlink:href="tvst-12-8-5-f006" position="float"/>
              </fig>
            </sec>
            <sec sec-type="discussion" id="sec4">
              <title>Discussion</title>
              <p>To our knowledge, this is the first randomized double-masked clinical trial assessing the effect of CMC-ATs on the OSM. Existing studies comparing AT formulations found minimal differences in subjective and objective outcomes among over-the-counter ATs but have yet to examine implications for the OSM.<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> Although ingested CMC has been shown to affect the gut microbiome and DES has been associated with unique OSMs, there is no prospective evidence explicitly linking topical CMC to the OSM.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> One study found changes in the OSM after topical application of sodium hyaluronate, but only compared preserved and non-preserved solutions.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Another study found no changes of the eyelid margin microbiome based on eyedrop preservatives.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> As a result, there are currently few reasons to choose one AT over another comparable formulation.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> To better understand how the OSM may mediate DES and AT therapy, we conducted this trial comparing the OSM effects of CMC-ATs with a control PEG-AT without CMC.</p>
              <sec id="sec4-1">
                <title>Participants, Compliance, and Dry Eye Symptoms</title>
                <p>Participants who completed the study were healthy adults without significant comorbidities, and there were no significant differences in the demographics of both study arms (<xref rid="tbl1" ref-type="table">Table</xref>). Compliance was also not statistically significantly different between the study arms and is unlikely to be a confounder.</p>
                <p>On enrollment, both study arms had comparable DES symptomatology, with OSDI scores less than 22 in 60 participants (90.1%). Therefore only the remaining six participants were considered to have moderate or severe DES. Both study arms experienced a small and statistically similar reduction in OSDI (<xref rid="fig2" ref-type="fig">Fig. 2</xref>). These results are consistent with prior studies and suggest that CMC-ATs and PEG-ATs are comparable treatments for DES, although the effect size was smaller in this study than previously reported. A masked, randomized, multicenter trial estimated a −10 reduction in OSDI after seven days of CMC-ATs, but participants in that trial had greater DES symptoms at baseline (mean OSDI = 41).<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref></p>
              </sec>
              <sec id="sec4-2">
                <title>OSM Diversity</title>
                <p>When examining OSM diversity, several measures have been reported in the literature.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> Alpha diversity is a measure of microbiome diversity within a single sample, whereas beta diversity is a measure of diversity between samples. Comparisons with other studies should consider that this analysis used the Chao-1 species richness estimate<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> and Shannon's diversity index<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> as measures of alpha diversity whereas UniFrac<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> was used as a measure of beta diversity.</p>
                <p>Similar Chao-1 estimates and Shannon diversities between the CMC and PEG study arms and time points (<xref rid="fig4" ref-type="fig">Figs. 4</xref>a, <xref rid="fig4" ref-type="fig">4</xref>b) indicate that neither CMC-AT nor PEG-AT interventions changed the alpha diversity of the OSMs. A randomized controlled study by Zhong et al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> on 16 healthy adults also found no significant differences in the OSM alpha diversity after two weeks of sodium hyaluronate ATs with or without benzalkonium chloride preservative. Another randomized controlled study on 36 patients by Willis et al.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> found small increases in alpha diversity after one month of saline solution eye washes in DES patients. However, alpha diversity was already higher in DES patients than in healthy controls at baseline, and this change was not found in healthy controls after saline solution eye washes.</p>
                <p>Overall, it appears that the high microbial diversity associated with DES may be resilient to topical elution or short-term interventions. Based on these two trials, it is possible that long-term AT use or saline elution exceeding one month may change alpha diversity, but there is no evidence that it may convert a DES-associated OSM into a healthy control-associated OSM by reducing alpha diversity. Some interventions such as topical prostaglandin therapy may increase alpha diversity,<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> but other interventions such as contact lens wear do not.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref> Successful treatment of DES may also reduce the alpha diversity, but none of these studies examined changes in DES symptomatology, and our study yielded only small reductions in DES symptomatology in healthy individuals, which do not represent successful treatment.</p>
                <p>There were no significant differences in UniFrac distances between study arms (<xref rid="fig5" ref-type="fig">Figs. 5</xref>a, <xref rid="fig5" ref-type="fig">5</xref>b) in this study, nor did principal coordinate analysis reveal any grouping related to AT use or study arm (<xref rid="fig5" ref-type="fig">Figs. 5</xref>c, <xref rid="fig5" ref-type="fig">5</xref>d). Zhong et al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> found distinct OSM beta diversities after two weeks of sodium hyaluronate ATs; their study was only controlled to compare preservatives in ATs and did not include controls using other ATs without sodium hyaluronate. Willis et al.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> did find unique beta diversities in DES patients, but no change associated with saline solution washes. Topical glaucoma medication and contact lens use, however, were associated with unique beta diversities in other studies. Overall, tear film elution does not appear to be associated with changes in OSM phylogenetic structure, but compounds such as sodium hyaluronate or behaviors such as contact lens wear change the taxa present on the conjunctiva. Therefore our study did not find that CMC or PEG are one of the compounds that affect beta diversity.</p>
                <p>Among the variables examined in our study, gender explained the separation in microbiome beta diversity among samples (<xref rid="fig5" ref-type="fig">Fig. 5</xref>e). In the United States, females are more likely to use ocular cosmetics such as eyeliner and mascara, and these represent reservoirs or vectors for microbial contamination.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> Pigment accumulation is also present in the conjunctiva and lacrimal system of long-term cosmetic users, which may also alter the metabolism and substrate of the microbial community.<xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> Other studies, however, have not found associations between gender and beta diversity.<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="bib51" ref-type="bibr"><sup>51</sup></xref> Nevertheless, our study was not powered to control for gender differences, and thus the significance of this finding remains uncertain.</p>
              </sec>
              <sec id="sec4-3">
                <title>OSM Composition</title>
                <p>Before the advent of metagenomic analysis using bacterial ribosomal RNA high-throughput sequencing, the ocular surface was thought to have low bacterial abundance and diversity dominated by onfallen skin flora.<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bib52" ref-type="bibr"><sup>52</sup></xref> Although conventional culture can reveal many of the bacterial species present in the OSM, metagenomic analysis has now revealed a community of low-abundance bacteria on the ocular surface which should be accounted for.<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> The ocular surface has a relatively stable core OSM shared between most individuals, consisting of common genera such as <italic toggle="yes">Corynebacterium, Staphylococcus, Streptococcus, Pseudomonas, Acinetobacter, and Propionibacterium</italic>.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> Less commonly identified genera such as <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Neisseria</italic> remain present in individuals after serial swabs, potentially representing an individual-specific core OSM as well. Other sporadically identified genera such as <italic toggle="yes">Acidovorax</italic> may be a result of contamination or are only transiently present on the ocular surface.</p>
                <p>In our participants, we found high relative abundances of <italic toggle="yes">Corynebacterium, Cutibacterium</italic>, <italic toggle="yes">Bacteroides, Pseudomonas</italic>, and <italic toggle="yes">Neisseriaceae</italic> genera consistent with previous analyses of the core OSM (<xref rid="fig6" ref-type="fig">Fig. 6</xref>a). High <italic toggle="yes">Cutibacterium</italic> abundance may be related to our anesthetized swab methodology.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> Sporadically identified <italic toggle="yes">Paraclostridium</italic>, <italic toggle="yes">Terrisporobacter, Lachnoclostridium,</italic> and <italic toggle="yes">Lachnospiraceae</italic> genera in the phylum <italic toggle="yes">Firmicutes</italic><italic toggle="yes">,</italic> as well as the genus <italic toggle="yes">Lawsonella</italic><italic toggle="yes">,</italic> were also identified in our participants at a higher abundance than previously reported, although 16S ribosomal analysis in some studies used other hypervariable regions such as V4 and V8, which may have skewed abundances.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> Unusual anaerobic taxa such as <italic toggle="yes">Paraclostridium</italic> were present in the OSM consistent with other studies<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref> and may either reside in low-oxygen environments such as the inferior fornix, nasolacrimal duct, and meibomian glands. They may also have digestive tract origins and migrate to the eye through droplets or direct contact. Unifrac analysis (<xref rid="fig3" ref-type="fig">Figs. 3</xref>c, <xref rid="fig3" ref-type="fig">3</xref>d) demonstrates that negative control swab samples had similar beta diversities and formed a distinct group. Therefore contamination is unlikely to account for the unusual but high-abundance taxa in <xref rid="fig6" ref-type="fig">Figure 6</xref>a.</p>
                <p>To identify differentially abundant taxa between groups, we used LEfSe (<xref rid="fig6" ref-type="fig">Figs. 6</xref>b, <xref rid="fig6" ref-type="fig">6</xref>c), a method for identifying statistically significant features that may explain differences between microbial samples. Treatment with CMC-ATs depleted <italic toggle="yes">Bacteroides</italic>, and no reduction was observed after PEG-ATs. In contrast, Zhong et al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> found an increase of <italic toggle="yes">Bacteroides</italic> (phylum <italic toggle="yes">Bacteroidetes</italic>) after treatment of sodium hyaluronate ATs.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> Previous characterization of the OSM has found an association between <italic toggle="yes">Bacteroidetes</italic> enrichment and DES.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Therefore treatment of DES with CMC-ATs may be related to <italic toggle="yes">Bacteroides</italic> depletion, although <italic toggle="yes">Bacteroides</italic> only represents one genus and not all of the <italic toggle="yes">Bacteroidetes</italic> phylum.</p>
                <p>CMC-ATs were associated with enrichment of periocular skin-associated phyla <italic toggle="yes">Actinobacteriota</italic> (<italic toggle="yes">Nocardioides, Agrococcus, Gordonia</italic>) and depletion of <italic toggle="yes">Firmicutes</italic> (<italic toggle="yes">Lachnoslostridium</italic> and other <italic toggle="yes">Lachnospiraceae</italic> genera) except for <italic toggle="yes">Coprococcus</italic> (phylum <italic toggle="yes">Firmicutes</italic>), which was enriched by CMC-AT treatment. Conversely, <italic toggle="yes">Actinobacteriota</italic> depletion and <italic toggle="yes">Firmicutes</italic> enrichment has been associated with meibomian gland dysfunction, so these phyla may also be markers for therapeutic response to CMC-ATs in DES.<xref rid="bib54" ref-type="bibr"><sup>54</sup></xref> PEG-ATs, however, had conflicting results at the <italic toggle="yes">Firmicutes</italic> phylum level, as <italic toggle="yes">Anaerostipes</italic> was depleted by PEG-AT treatment while <italic toggle="yes">Tyzzerella</italic> was enriched. It remains to be seen whether <italic toggle="yes">Firmicutes</italic> genera represent useful markers for DES and AT treatment or if these are findings specific to our population.</p>
                <p>Both CMC-AT and PEG-AT treatments were associated with enrichment of <italic toggle="yes">Proteobacteria</italic> genera (<italic toggle="yes">Noviherbaspirillum, Pelomonas, Sphingomonas, Brevundimonas</italic>, and <italic toggle="yes">Citrobacter</italic>) and genera among other bacterial families (<italic toggle="yes">Enterobacteriaceae, Comamonadaceae,</italic> and <italic toggle="yes">Acetobacteraceae</italic>). PEG-ATs also enriched the genus <italic toggle="yes">Morganella</italic>, but CMC-ATs had the opposite effect by depleting <italic toggle="yes">Morganella</italic>. Although DES has been associated with <italic toggle="yes">Proteobacteria</italic> depletion,<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> our participants overall experienced small improvements in DES symptoms after either AT intervention. The core genus whose depletion is associated with DES, <italic toggle="yes">Pseudomonas,</italic> was also unaffected by either AT treatment in our study. Instead, enrichment of <italic toggle="yes">Proteobacteria</italic> at the follow-up visit may be a result of greater swab depth, after the participants or investigators became more familiar and comfortable with the procedure.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref></p>
                <p>Overall, CMC-ATs were associated with enrichment of <italic toggle="yes">Bacteriodota</italic> and <italic toggle="yes">Actinobacteriota</italic>, and possibly depletion of <italic toggle="yes">Firmicutes</italic> as well. PEG-ATs were not associated with any of these changes, but both AT treatments resulted in <italic toggle="yes">Proteobacteria</italic> enrichment. Although CMC-ATs appeared to shift the OSM away from DES and toward a normal eye, it should be noted that this study was conducted on generally healthy patients without significant DES, and both AT arms experienced comparable reductions in DES symptomatology. Only one week was given as a washout period, which may not have been sufficient to revert an OSM to wild type. Furthermore, swabs were collected in 2022, when mask-wearing was mandatory in clinical spaces because of the COVID pandemic, which may have influenced the OSM.<xref rid="bib55" ref-type="bibr"><sup>55</sup></xref><sup>,</sup><xref rid="bib56" ref-type="bibr"><sup>56</sup></xref> Interestingly, <italic toggle="yes">Nocardioides</italic> and <italic toggle="yes">Pseudomonas</italic> genera were detected, but neither pathogenic <italic toggle="yes">Nocardia</italic> nor <italic toggle="yes">Pseudomonas aeruginosa</italic> were identified in any participant, and no ocular infections were reported in our patient population.</p>
              </sec>
              <sec id="sec4-4">
                <title>Study Limitations</title>
                <p>Interpretation of this study should consider that AT compliance was participant-reported and not actively monitored (i.e., checking empty vials) as other studies have done.<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> In the real-world setting, patients generally do not reliably adhere to a strict AT regimen, so a modified intention-to-treat analysis was chosen for this study, wherein only participants who missed the follow-up survey or follow-up swab were excluded from the analysis.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> Considering that few of our participants had DES and OSDI reductions were small, the Hawthorne effect may also have resulted in study bias.<xref rid="bib59" ref-type="bibr"><sup>59</sup></xref> Our study also had no objective measures for DES such as Schirmer's test, tear breakup time, or tear osmolarity to confirm reduction of DES signs.</p>
                <p>Although the objective of this study was to identify effects of CMC on the OSM, neither pure CMC solution nor a perfect control were available. Instead, commercially available ATs were chosen, with different inactive ingredients such as ionic salt buffers, organic (Aminomethylpropanol) salt buffers, hyaluronate, and sorbitol. Although these differences may confound results, their concentration is relatively low. Participants were also compared by time point with no differences in OSM diversity, suggesting that the impacts of these ingredients are not significant confounding factors.</p>
                <p>Interpretation of these microbiome results should consider that this was a bilateral pooled, anesthetized, and deep conjunctival swab with nylon flocking. The bacterial microbiome at the lid margin may be different from the inferior fornix, and samples may also be affected by anesthesia and swab type.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref><sup>,</sup><xref rid="bib60" ref-type="bibr"><sup>60</sup></xref> Although samples could be collected with a softer swab and without anesthesia, participants may not tolerate full-depth swabs reliably. Analysis should also consider the segment of 16S ribosome chosen (V1-V3), because the region chosen may bias bacterial relative abundances.<xref rid="bib53" ref-type="bibr"><sup>53</sup></xref></p>
              </sec>
            </sec>
            <sec sec-type="conclusion" id="sec5">
              <title>Conclusion</title>
              <p>In this double-masked randomized controlled trial, CMC AT treatment increased <italic toggle="yes">Bacteroides</italic> and <italic toggle="yes">Actinobacteriota</italic> but decreased <italic toggle="yes">Firmicutes</italic> bacteria in the OSM of healthy adults, compared to control PEG AT treatment. Bacterial genera from a core OSM were identified but were unaffected by AT treatment. Neither CMC nor PEG ATs changed the OSM diversity, although both treatments resulted in small improvements in dry eye symptoms. These results suggest that CMC-induced changes in the OSM at the genus level may mediate improvements in dry eye symptoms, but CMC ATs are not superior to PEG ATs for the treatment of mild DES.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>Supported in part by NIAID R21 AI150250, VA CSR&amp;D Merit Review I01CX001391, and the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine. The funding organization had no role in the design or conduct of this research.</p>
              <p content-type="COI-statement">Disclosure: <bold>Y. Zhou</bold>, None; <bold>G.S. Sidhu</bold>, None; <bold>J.A. Whitlock</bold>, None; <bold>B. Abdelmalik</bold>, None; <bold>Z. Mayer</bold>, None; <bold>Y. Li</bold>, None; <bold>G.P. Wang</bold>, None; <bold>W.A. Steigleman</bold>, None</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="bib1">
                <label>1.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stapleton</surname><given-names>F</given-names></string-name>, <string-name><surname>Alves</surname><given-names>M</given-names></string-name>, <string-name><surname>Bunya</surname><given-names>VY</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>TFOS DEWS II epidemiology report</article-title>. <source><italic toggle="yes">Ocul Surf</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>15</volume>: <fpage>334</fpage>–<lpage>365</lpage>.<pub-id pub-id-type="pmid">28736337</pub-id></mixed-citation>
              </ref>
              <ref id="bib2">
                <label>2.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Farrand</surname><given-names>KF</given-names></string-name>, <string-name><surname>Fridman</surname><given-names>M</given-names></string-name>, <string-name><surname>Stillman</surname><given-names>I</given-names></string-name>, <string-name><surname>Schaumberg</surname><given-names>DA.</given-names></string-name></person-group><article-title>Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>182</volume>: <fpage>90</fpage>–<lpage>98</lpage>.<pub-id pub-id-type="pmid">28705660</pub-id></mixed-citation>
              </ref>
              <ref id="bib3">
                <label>3.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pult</surname><given-names>H</given-names></string-name>, <string-name><surname>Purslow</surname><given-names>C</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>PJ.</given-names></string-name></person-group><article-title>The relationship between clinical signs and dry eye symptoms</article-title>. <source><italic toggle="yes">Eye</italic></source><italic toggle="yes">.</italic><year>2011</year>; <volume>25</volume>: <fpage>502</fpage>–<lpage>510</lpage>.<pub-id pub-id-type="pmid">21252949</pub-id></mixed-citation>
              </ref>
              <ref id="bib4">
                <label>4.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lemp</surname><given-names>MA.</given-names></string-name></person-group><article-title>Report of the national eye institute/industry workshop on clinical trials in dry eyes</article-title>. <source><italic toggle="yes">CLAO J</italic></source><italic toggle="yes">.</italic><year>1995</year>; <volume>21</volume>: <fpage>221</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">8565190</pub-id></mixed-citation>
              </ref>
              <ref id="bib5">
                <label>5.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gipson</surname><given-names>IK</given-names></string-name>, <string-name><surname>Argüeso</surname><given-names>P</given-names></string-name>, <string-name><surname>Beuerman</surname><given-names>R</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Research in dry eye: report of the research subcommittee of the international dry eye workshop</article-title>. <source><italic toggle="yes">Ocul Surf</italic></source><italic toggle="yes">.</italic><year>2007</year>; <volume>5</volume>: <fpage>179</fpage>–<lpage>193</lpage>.<pub-id pub-id-type="pmid">17508121</pub-id></mixed-citation>
              </ref>
              <ref id="bib6">
                <label>6.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chauhan</surname><given-names>SK</given-names></string-name>, <string-name><surname>Lee</surname><given-names>HS</given-names></string-name>, <string-name><surname>Saban</surname><given-names>DR</given-names></string-name>, <string-name><surname>Dana</surname><given-names>R.</given-names></string-name></person-group><article-title>Chronic dry eye disease is principally mediated by effector memory Th17 cells</article-title>. <source><italic toggle="yes">Mucosal Immunol</italic></source><italic toggle="yes">.</italic><year>2014</year>; <volume>7</volume>: <fpage>38</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="pmid">23571503</pub-id></mixed-citation>
              </ref>
              <ref id="bib7">
                <label>7.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stevenson</surname><given-names>W</given-names></string-name>, <string-name><surname>Chauhan</surname><given-names>SK</given-names></string-name>, <string-name><surname>Dana</surname><given-names>R.</given-names></string-name></person-group><article-title>Dry eye disease: an immune-mediated ocular surface disorder</article-title>. <source><italic toggle="yes">Arch Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2012</year>; <volume>130</volume>: <fpage>90</fpage>–<lpage>100</lpage>.<pub-id pub-id-type="pmid">22232476</pub-id></mixed-citation>
              </ref>
              <ref id="bib8">
                <label>8.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petrillo</surname><given-names>F</given-names></string-name>, <string-name><surname>Pignataro</surname><given-names>D</given-names></string-name>, <string-name><surname>Lavano</surname><given-names>MA</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Current evidence on the ocular surface microbiota and related diseases</article-title>. <source><italic toggle="yes">Microorganisms</italic></source><italic toggle="yes">.</italic><year>2020</year>; <volume>8</volume>: <fpage>1033</fpage>.<pub-id pub-id-type="pmid">32668575</pub-id></mixed-citation>
              </ref>
              <ref id="bib9">
                <label>9.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Graham</surname><given-names>JE</given-names></string-name>, <string-name><surname>Moore</surname><given-names>JE</given-names></string-name>, <string-name><surname>Jiru</surname><given-names>X</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Ocular pathogen or commensal: a PCR-based study of surface bacterial flora in normal and dry eyes</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2007</year>; <volume>48</volume>: <fpage>5616</fpage>–<lpage>5623</lpage>.<pub-id pub-id-type="pmid">18055811</pub-id></mixed-citation>
              </ref>
              <ref id="bib10">
                <label>10.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Willcox</surname><given-names>MD.</given-names></string-name></person-group><article-title>Characterization of the normal microbiota of the ocular surface</article-title>. <source><italic toggle="yes">Exp Eye Res</italic></source><italic toggle="yes">.</italic><year>2013</year>; <volume>117</volume>: <fpage>99</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="pmid">23797046</pub-id></mixed-citation>
              </ref>
              <ref id="bib11">
                <label>11.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miller</surname><given-names>D</given-names></string-name>, <string-name><surname>Shestopalov</surname><given-names>VI</given-names></string-name>, <string-name><surname>Iovieno</surname><given-names>A</given-names></string-name>, <string-name><surname>O'Brien</surname><given-names>T</given-names></string-name>, <string-name><surname>Alfonso</surname><given-names>EC.</given-names></string-name></person-group><article-title>Comparison of routine culture and metagenomics for discovery of microbial communities (microbiota) at the ocular surface</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2010</year>; <volume>51</volume>: <fpage>2377</fpage>–<lpage>2377</lpage>.</mixed-citation>
              </ref>
              <ref id="bib12">
                <label>12.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>Q</given-names></string-name>, <string-name><surname>Brulc</surname><given-names>JM</given-names></string-name>, <string-name><surname>Iovieno</surname><given-names>A</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Diversity of bacteria at healthy human conjunctiva</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2011</year>; <volume>52</volume>: <fpage>5408</fpage>–<lpage>5413</lpage>.<pub-id pub-id-type="pmid">21571682</pub-id></mixed-citation>
              </ref>
              <ref id="bib13">
                <label>13.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Doan</surname><given-names>T</given-names></string-name>, <string-name><surname>Akileswaran</surname><given-names>L</given-names></string-name>, <string-name><surname>Andersen</surname><given-names>D</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Paucibacterial microbiome and resident DNA virome of the healthy conjunctiva</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2016</year>; <volume>57</volume>: <fpage>5116</fpage>–<lpage>5126</lpage>.<pub-id pub-id-type="pmid">27699405</pub-id></mixed-citation>
              </ref>
              <ref id="bib14">
                <label>14.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shivaji</surname><given-names>S</given-names></string-name>, <string-name><surname>Jayasudha</surname><given-names>R</given-names></string-name>, <string-name><surname>Sai Prashanthi</surname><given-names>G</given-names></string-name>, <string-name><surname>Kalyana Chakravarthy</surname><given-names>S</given-names></string-name>, <string-name><surname>Sharma</surname><given-names>S</given-names></string-name></person-group>. <article-title>The human ocular surface fungal microbiome</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>60</volume>: <fpage>451</fpage>–<lpage>459</lpage>.<pub-id pub-id-type="pmid">30703210</pub-id></mixed-citation>
              </ref>
              <ref id="bib15">
                <label>15.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prashanthi</surname><given-names>GS</given-names></string-name>, <string-name><surname>Jayasudha</surname><given-names>R</given-names></string-name>, <string-name><surname>Chakravarthy</surname><given-names>SK</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Alterations in the ocular surface fungal microbiome in fungal keratitis patients</article-title>. <source><italic toggle="yes">Microorganisms</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>7</volume>: <fpage>309</fpage>.<pub-id pub-id-type="pmid">31480776</pub-id></mixed-citation>
              </ref>
              <ref id="bib16">
                <label>16.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delbeke</surname><given-names>H</given-names></string-name>, <string-name><surname>Younas</surname><given-names>S</given-names></string-name>, <string-name><surname>Casteels</surname><given-names>I</given-names></string-name>, <string-name><surname>Joossens</surname><given-names>M.</given-names></string-name></person-group><article-title>Current knowledge on the human eye microbiome: a systematic review of available amplicon and metagenomic sequencing data</article-title>. <source><italic toggle="yes">Acta Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>99</volume>: <fpage>16</fpage>–<lpage>25</lpage>.<pub-id pub-id-type="pmid">32602257</pub-id></mixed-citation>
              </ref>
              <ref id="bib17">
                <label>17.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aragona</surname><given-names>P</given-names></string-name>, <string-name><surname>Baudouin</surname><given-names>C</given-names></string-name>, <string-name><surname>Benitez Del Castillo</surname><given-names>JM</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders</article-title>. <source><italic toggle="yes">Surv Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>66</volume>: <fpage>907</fpage>–<lpage>925</lpage>.<pub-id pub-id-type="pmid">33819460</pub-id></mixed-citation>
              </ref>
              <ref id="bib18">
                <label>18.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wen</surname><given-names>X</given-names></string-name>, <string-name><surname>Miao</surname><given-names>L</given-names></string-name>, <string-name><surname>Deng</surname><given-names>Y</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>The influence of age and sex on ocular surface microbiota in healthy adults</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>58</volume>: <fpage>6030</fpage>–<lpage>6037</lpage>.<pub-id pub-id-type="pmid">29196767</pub-id></mixed-citation>
              </ref>
              <ref id="bib19">
                <label>19.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stapleton</surname><given-names>F</given-names></string-name>, <string-name><surname>Keay</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Sanfilippo</surname><given-names>PG</given-names></string-name>, <string-name><surname>Katiyar</surname><given-names>S</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>KP</given-names></string-name>, <string-name><surname>Naduvilath</surname><given-names>T.</given-names></string-name></person-group><article-title>Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia</article-title>. <source><italic toggle="yes">Am J Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2007</year>; <volume>144</volume>: <fpage>690</fpage>–<lpage>698</lpage>.<pub-id pub-id-type="pmid">17727808</pub-id></mixed-citation>
              </ref>
              <ref id="bib20">
                <label>20.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shin</surname><given-names>H</given-names></string-name>, <string-name><surname>Price</surname><given-names>K</given-names></string-name>, <string-name><surname>Albert</surname><given-names>L</given-names></string-name>, <string-name><surname>Dodick</surname><given-names>J</given-names></string-name>, <string-name><surname>Park</surname><given-names>L</given-names></string-name>, <string-name><surname>Dominguez-Bello</surname><given-names>MG.</given-names></string-name></person-group><article-title>Changes in the eye microbiota associated with contact lens wearing</article-title>. <source><italic toggle="yes">mBio</italic></source><italic toggle="yes">.</italic><year>2016</year>; <volume>7</volume>(<issue>2</issue>): <fpage>e00198</fpage>.<pub-id pub-id-type="pmid">27006462</pub-id></mixed-citation>
              </ref>
              <ref id="bib21">
                <label>21.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>Z</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Comparative portrayal of ocular surface microbe with and without dry eye</article-title>. <source><italic toggle="yes">J Microbiol</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>57</volume>: <fpage>1025</fpage>–<lpage>1032</lpage>.<pub-id pub-id-type="pmid">31463790</pub-id></mixed-citation>
              </ref>
              <ref id="bib22">
                <label>22.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Willis</surname><given-names>KA</given-names></string-name>, <string-name><surname>Postnikoff</surname><given-names>CK</given-names></string-name>, <string-name><surname>Freeman</surname><given-names>A</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>The closed eye harbours a unique microbiome in dry eye disease</article-title>. <source><italic toggle="yes">Sci Rep</italic></source><italic toggle="yes">.</italic><year>2020</year>; <volume>10</volume>: <fpage>12035</fpage>.<pub-id pub-id-type="pmid">32694705</pub-id></mixed-citation>
              </ref>
              <ref id="bib23">
                <label>23.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gayton</surname><given-names>JL.</given-names></string-name></person-group><article-title>Etiology, prevalence, and treatment of dry eye disease</article-title>. <source><italic toggle="yes">Clin Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2009</year>; <volume>3</volume>: <fpage>405</fpage>–<lpage>412</lpage>.<pub-id pub-id-type="pmid">19688028</pub-id></mixed-citation>
              </ref>
              <ref id="bib24">
                <label>24.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kim</surname><given-names>M</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Mehra</surname><given-names>D</given-names></string-name>, <string-name><surname>Sabater</surname><given-names>AL</given-names></string-name>, <string-name><surname>Galor</surname><given-names>A.</given-names></string-name></person-group><article-title>Dry eye: why artificial tears are not always the answer</article-title>. <source><italic toggle="yes">BMJ Open Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>6</volume>(<issue>1</issue>): <fpage>e000697</fpage>.</mixed-citation>
              </ref>
              <ref id="bib25">
                <label>25.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Jeyalatha M</surname><given-names>V</given-names></string-name>, <string-name><surname>Qu</surname><given-names>Y</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Dry eye management: targeting the ocular surface microenvironment</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>18</volume>: <fpage>1398</fpage>.<pub-id pub-id-type="pmid">28661456</pub-id></mixed-citation>
              </ref>
              <ref id="bib26">
                <label>26.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arshinoff</surname><given-names>S</given-names></string-name>, <string-name><surname>Hofmann</surname><given-names>I</given-names></string-name>, <string-name><surname>Nae</surname><given-names>H</given-names></string-name></person-group>. <article-title>Role of rheology in tears and artificial tears</article-title>. <source><italic toggle="yes">J Cataract Refract Surg</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>47</volume>: <fpage>655</fpage>–<lpage>661</lpage>.<pub-id pub-id-type="pmid">33278231</pub-id></mixed-citation>
              </ref>
              <ref id="bib27">
                <label>27.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chassaing</surname><given-names>B</given-names></string-name>, <string-name><surname>Compher</surname><given-names>C</given-names></string-name>, <string-name><surname>Bonhomme</surname><given-names>B</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Randomized controlled-feeding study of dietary emulsifier carboxymethylcellulose reveals detrimental impacts on the gut microbiota and metabolome</article-title>. <source><italic toggle="yes">Gastroenterology</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>162</volume>: <fpage>743</fpage>–<lpage>756</lpage>.<pub-id pub-id-type="pmid">34774538</pub-id></mixed-citation>
              </ref>
              <ref id="bib28">
                <label>28.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martino</surname><given-names>JV</given-names></string-name>, <string-name><surname>Van Limbergen</surname><given-names>J</given-names></string-name>, <string-name><surname>Cahill</surname><given-names>LE.</given-names></string-name></person-group><article-title>The role of carrageenan and carboxymethylcellulose in the development of intestinal inflammation</article-title>. <source><italic toggle="yes">Front Pediatr</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>5</volume>: <fpage>96</fpage>.<pub-id pub-id-type="pmid">28507982</pub-id></mixed-citation>
              </ref>
              <ref id="bib29">
                <label>29.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chang</surname><given-names>C-CJ</given-names></string-name>, <string-name><surname>Somohano</surname><given-names>K</given-names></string-name>, <string-name><surname>Zemsky</surname><given-names>C</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Topical glaucoma therapy is associated with alterations of the ocular surface microbiome</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>63</volume>: <fpage>32</fpage>–<lpage>32</lpage>.</mixed-citation>
              </ref>
              <ref id="bib30">
                <label>30.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lim</surname><given-names>S-H</given-names></string-name>, <string-name><surname>Shin</surname><given-names>JH</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J-W</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Seo</surname><given-names>JH.</given-names></string-name></person-group><article-title>Differences in the eyelid and buccal microbiome of glaucoma patients receiving long-term administration of prostaglandin analog drops</article-title>. <source><italic toggle="yes">Graefes Arch Clin Exp Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>259</volume>: <fpage>3055</fpage>–<lpage>3065</lpage>.<pub-id pub-id-type="pmid">33961112</pub-id></mixed-citation>
              </ref>
              <ref id="bib31">
                <label>31.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delbeke</surname><given-names>H</given-names></string-name>, <string-name><surname>Casteels</surname><given-names>I</given-names></string-name>, <string-name><surname>Joossens</surname><given-names>M.</given-names></string-name></person-group><article-title>The effect of topical anesthetics on 16s ribosomal ribonucleic acid amplicon sequencing results in ocular surface microbiome research</article-title>. <source><italic toggle="yes">Transl Vis Sci Technol</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>11</volume>(<issue>3</issue>): <fpage>2</fpage>–<lpage>2</lpage>.</mixed-citation>
              </ref>
              <ref id="bib32">
                <label>32.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhong</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fang</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X</given-names></string-name>, <string-name><surname>Lin</surname><given-names>YA</given-names></string-name>, <string-name><surname>Wu</surname><given-names>H</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.</given-names></string-name></person-group><article-title>Effects of sodium hyaluronate eye drops with or without preservatives on ocular surface bacterial microbiota</article-title>. <source><italic toggle="yes">Front Med</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>9</volume>: <fpage>793565</fpage>.</mixed-citation>
              </ref>
              <ref id="bib33">
                <label>33.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ozkan</surname><given-names>J</given-names></string-name>, <string-name><surname>Nielsen</surname><given-names>S</given-names></string-name>, <string-name><surname>Diez-Vives</surname><given-names>C</given-names></string-name>, <string-name><surname>Coroneo</surname><given-names>M</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>T</given-names></string-name>, <string-name><surname>Willcox</surname><given-names>M.</given-names></string-name></person-group><article-title>Temporal stability and composition of the ocular surface microbiome</article-title>. <source><italic toggle="yes">Sci Rep</italic></source><italic toggle="yes">.</italic><year>2017</year>; <volume>7</volume>: <fpage>9880</fpage>.<pub-id pub-id-type="pmid">28852195</pub-id></mixed-citation>
              </ref>
              <ref id="bib34">
                <label>34.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schiffman</surname><given-names>RM</given-names></string-name>, <string-name><surname>Christianson</surname><given-names>MD</given-names></string-name>, <string-name><surname>Jacobsen</surname><given-names>G</given-names></string-name>, <string-name><surname>Hirsch</surname><given-names>JD</given-names></string-name>, <string-name><surname>Reis</surname><given-names>BL.</given-names></string-name></person-group><article-title>Reliability and validity of the ocular surface disease index</article-title>. <source><italic toggle="yes">Arch Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2000</year>; <volume>118</volume>: <fpage>615</fpage>–<lpage>621</lpage>.<pub-id pub-id-type="pmid">10815152</pub-id></mixed-citation>
              </ref>
              <ref id="bib35">
                <label>35.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dougherty</surname><given-names>BE</given-names></string-name>, <string-name><surname>Nichols</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Nichols</surname><given-names>KK.</given-names></string-name></person-group><article-title>Rasch analysis of the Ocular Surface Disease Index (OSDI)</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2011</year>; <volume>52</volume>: <fpage>8630</fpage>–<lpage>8635</lpage>.<pub-id pub-id-type="pmid">21948646</pub-id></mixed-citation>
              </ref>
              <ref id="bib36">
                <label>36.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lehenaff</surname><given-names>R</given-names></string-name>, <string-name><surname>Tamashiro</surname><given-names>R</given-names></string-name>, <string-name><surname>Nascimento</surname><given-names>MM</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Subgingival microbiome of deep and shallow periodontal sites in patients with rheumatoid arthritis: a pilot study</article-title>. <source><italic toggle="yes">BMC Oral Health</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>21</volume>: <fpage>248</fpage>.<pub-id pub-id-type="pmid">33964928</pub-id></mixed-citation>
              </ref>
              <ref id="bib37">
                <label>37.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martin</surname><given-names>M.</given-names></string-name></person-group><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>. <source><italic toggle="yes">EMBnetjournal</italic></source>. <year>2011</year>; <volume>17</volume>(<issue>1)</issue>: <fpage>10</fpage>–<lpage>12</lpage>.</mixed-citation>
              </ref>
              <ref id="bib38">
                <label>38.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bolyen</surname><given-names>E</given-names></string-name>, <string-name><surname>Rideout</surname><given-names>JR</given-names></string-name>, <string-name><surname>Dillon</surname><given-names>MR</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2</article-title>. <source><italic toggle="yes">Nat Biotechnol</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>37</volume>: <fpage>852</fpage>–<lpage>857</lpage>.<pub-id pub-id-type="pmid">31341288</pub-id></mixed-citation>
              </ref>
              <ref id="bib39">
                <label>39.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Segata</surname><given-names>N</given-names></string-name>, <string-name><surname>Izard</surname><given-names>J</given-names></string-name>, <string-name><surname>Waldron</surname><given-names>L</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Metagenomic biomarker discovery and explanation</article-title>. <source><italic toggle="yes">Genome Biol</italic></source><italic toggle="yes">.</italic><year>2011</year>; <volume>12</volume>(<issue>6</issue>): <fpage>R60</fpage>.<pub-id pub-id-type="pmid">21702898</pub-id></mixed-citation>
              </ref>
              <ref id="bib40">
                <label>40.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moshirfar</surname><given-names>M</given-names></string-name>, <string-name><surname>Pierson</surname><given-names>K</given-names></string-name>, <string-name><surname>Hanamaikai</surname><given-names>K</given-names></string-name>, <string-name><surname>Santiago-Caban</surname><given-names>L</given-names></string-name>, <string-name><surname>Muthappan</surname><given-names>V</given-names></string-name>, <string-name><surname>Passi</surname><given-names>SF.</given-names></string-name></person-group><article-title>Artificial tears potpourri: a literature review</article-title>. <source><italic toggle="yes">Clin Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2014</year>; <volume>8</volume>: <fpage>1419</fpage>–<lpage>1433</lpage>.<pub-id pub-id-type="pmid">25114502</pub-id></mixed-citation>
              </ref>
              <ref id="bib41">
                <label>41.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zilliox</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Gange</surname><given-names>WS</given-names></string-name>, <string-name><surname>Kuffel</surname><given-names>G</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Assessing the ocular surface microbiome in severe ocular surface diseases</article-title>. <source><italic toggle="yes">Ocular Surf</italic></source><italic toggle="yes">.</italic><year>2020</year>; <volume>18</volume>: <fpage>706</fpage>–<lpage>712</lpage>.</mixed-citation>
              </ref>
              <ref id="bib42">
                <label>42.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Priluck</surname><given-names>A</given-names></string-name>, <string-name><surname>Ramulu</surname><given-names>P</given-names></string-name>, <string-name><surname>Dosto</surname><given-names>N</given-names></string-name>, <string-name><surname>Quigley</surname><given-names>H</given-names></string-name>, <string-name><surname>Abraham</surname><given-names>A.</given-names></string-name></person-group><article-title>Validation of 16S rRNA gene sequencing of the periocular microbiome and lack of alteration by topical eyedrops</article-title>. <source><italic toggle="yes">Transl Vis Sci Technol</italic></source><italic toggle="yes">.</italic><year>2023</year>; <volume>12</volume>: <fpage>32</fpage>–<lpage>32</lpage>.</mixed-citation>
              </ref>
              <ref id="bib43">
                <label>43.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tong</surname><given-names>L</given-names></string-name>, <string-name><surname>Petznick</surname><given-names>A</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S</given-names></string-name>, <string-name><surname>Tan</surname><given-names>J.</given-names></string-name></person-group><article-title>Choice of artificial tear formulation for patients with dry eye: where do we start?</article-title><source><italic toggle="yes">Cornea</italic></source><italic toggle="yes">.</italic><year>2012</year>; <volume>31</volume>(<issue>Suppl 1</issue>): <fpage>S32</fpage>–<lpage>S36</lpage>.<pub-id pub-id-type="pmid">23038032</pub-id></mixed-citation>
              </ref>
              <ref id="bib44">
                <label>44.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aragona</surname><given-names>P</given-names></string-name>, <string-name><surname>Benítez-Del-Castillo</surname><given-names>JM</given-names></string-name>, <string-name><surname>Coroneo</surname><given-names>MT</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Safety and efficacy of a preservative-free artificial tear containing carboxymethylcellulose and hyaluronic acid for dry eye disease: a randomized, controlled, multicenter 3-month study</article-title>. <source><italic toggle="yes">Clin Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2020</year>; <volume>14</volume>: <fpage>2951</fpage>–<lpage>2963</lpage>.<pub-id pub-id-type="pmid">33061281</pub-id></mixed-citation>
              </ref>
              <ref id="bib45">
                <label>45.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kers</surname><given-names>JG</given-names></string-name>, <string-name><surname>Saccenti</surname><given-names>E.</given-names></string-name></person-group><article-title>The power of microbiome studies: some considerations on which alpha and beta metrics to use and how to report results</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>12</volume>: <fpage>796025</fpage>.<pub-id pub-id-type="pmid">35310396</pub-id></mixed-citation>
              </ref>
              <ref id="bib46">
                <label>46.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chao</surname><given-names>A</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>C-H</given-names></string-name>, <string-name><surname>Hsieh</surname><given-names>TC</given-names></string-name>, <string-name><surname>Davis</surname><given-names>T</given-names></string-name>, <string-name><surname>Nipperess</surname><given-names>DA</given-names></string-name>, <string-name><surname>Faith</surname><given-names>DP.</given-names></string-name></person-group><article-title>Rarefaction and extrapolation of phylogenetic diversity</article-title>. <source><italic toggle="yes">Methods Ecol Evolution</italic></source><italic toggle="yes">.</italic><year>2015</year>; <volume>6</volume>: <fpage>380</fpage>–<lpage>388</lpage>.</mixed-citation>
              </ref>
              <ref id="bib47">
                <label>47.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shannon</surname><given-names>CE.</given-names></string-name></person-group><article-title>A mathematical theory of communication</article-title>. <source><italic toggle="yes">Bell Sys Tech J</italic></source><italic toggle="yes">.</italic><year>1948</year>; <volume>27</volume>: <fpage>379</fpage>–<lpage>423</lpage>.</mixed-citation>
              </ref>
              <ref id="bib48">
                <label>48.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lozupone</surname><given-names>C</given-names></string-name>, <string-name><surname>Knight</surname><given-names>R.</given-names></string-name></person-group><article-title>UniFrac: a new phylogenetic method for comparing microbial communities</article-title>. <source><italic toggle="yes">Appl Environ Microbiol</italic></source><italic toggle="yes">.</italic><year>2005</year>; <volume>71</volume>: <fpage>8228</fpage>–<lpage>8235</lpage>.<pub-id pub-id-type="pmid">16332807</pub-id></mixed-citation>
              </ref>
              <ref id="bib49">
                <label>49.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yazdani</surname><given-names>M</given-names></string-name>, <string-name><surname>Elgstøen</surname><given-names>KBP</given-names></string-name>, <string-name><surname>Utheim</surname><given-names>TP.</given-names></string-name></person-group><article-title>Eye make-up products and dry eye disease: a mini review</article-title>. <source><italic toggle="yes">Curr Eye Res</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>47</volume>: <fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">34365876</pub-id></mixed-citation>
              </ref>
              <ref id="bib50">
                <label>50.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ng</surname><given-names>A</given-names></string-name>, <string-name><surname>Evans</surname><given-names>K</given-names></string-name>, <string-name><surname>North</surname><given-names>RV</given-names></string-name>, <string-name><surname>Jones</surname><given-names>L</given-names></string-name>, <string-name><surname>Purslow</surname><given-names>C.</given-names></string-name></person-group><article-title>Impact of eye cosmetics on the eye, adnexa, and ocular surface</article-title>. <source><italic toggle="yes">Eye Cont Lens</italic></source><italic toggle="yes">.</italic><year>2016</year>; <volume>42</volume>: <fpage>211</fpage>–<lpage>220</lpage>.</mixed-citation>
              </ref>
              <ref id="bib51">
                <label>51.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cavuoto</surname><given-names>KM</given-names></string-name>, <string-name><surname>Mendez</surname><given-names>R</given-names></string-name>, <string-name><surname>Miller</surname><given-names>D</given-names></string-name>, <string-name><surname>Galor</surname><given-names>A</given-names></string-name>, <string-name><surname>Banerjee</surname><given-names>S.</given-names></string-name></person-group><article-title>Effect of clinical parameters on the ocular surface microbiome in children and adults</article-title>. <source><italic toggle="yes">Clin Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2018</year>; <volume>12</volume>: <fpage>1189</fpage>–<lpage>1197</lpage>.<pub-id pub-id-type="pmid">30013312</pub-id></mixed-citation>
              </ref>
              <ref id="bib52">
                <label>52.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pallen</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Loman</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Penn</surname><given-names>CW.</given-names></string-name></person-group><article-title>High-throughput sequencing and clinical microbiology: progress, opportunities and challenges</article-title>. <source><italic toggle="yes">Curr Opin Microbiol</italic></source><italic toggle="yes">.</italic><year>2010</year>; <volume>13</volume>: <fpage>625</fpage>–<lpage>631</lpage>.<pub-id pub-id-type="pmid">20843733</pub-id></mixed-citation>
              </ref>
              <ref id="bib53">
                <label>53.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ozkan</surname><given-names>J</given-names></string-name>, <string-name><surname>Willcox</surname><given-names>MD.</given-names></string-name></person-group><article-title>The ocular microbiome: molecular characterisation of a unique and low microbial environment</article-title>. <source><italic toggle="yes">Curr Eye Res</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>44</volume>: <fpage>685</fpage>–<lpage>694</lpage>.<pub-id pub-id-type="pmid">30640553</pub-id></mixed-citation>
              </ref>
              <ref id="bib54">
                <label>54.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>X</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>W</given-names></string-name>, <string-name><surname>Lin</surname><given-names>P</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name></person-group><article-title>Composition and diversity of bacterial community on the ocular surface of patients with meibomian gland dysfunction</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2019</year>; <volume>60</volume>: <fpage>4774</fpage>–<lpage>4783</lpage>.<pub-id pub-id-type="pmid">31738825</pub-id></mixed-citation>
              </ref>
              <ref id="bib55">
                <label>55.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pandey</surname><given-names>SK</given-names></string-name>, <string-name><surname>Sharma</surname><given-names>V.</given-names></string-name></person-group><article-title>Mask-associated dry eye disease and dry eye due to prolonged screen time: are we heading towards a new dry eye epidemic during the COVID-19 era?</article-title><source><italic toggle="yes">Indian J Ophthalmol</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>69</volume>: <fpage>448</fpage>–<lpage>449</lpage>.<pub-id pub-id-type="pmid">33380621</pub-id></mixed-citation>
              </ref>
              <ref id="bib56">
                <label>56.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delanghe</surname><given-names>L</given-names></string-name>, <string-name><surname>Cauwenberghs</surname><given-names>E</given-names></string-name>, <string-name><surname>Spacova</surname><given-names>I</given-names></string-name>, <etal>et al</etal>.</person-group><article-title>Cotton and surgical face masks in community settings: bacterial contamination and face mask hygiene</article-title>. <source><italic toggle="yes">Front Med</italic></source><italic toggle="yes">.</italic><year>2021</year>; <volume>8</volume>: <fpage>732047</fpage>.</mixed-citation>
              </ref>
              <ref id="bib57">
                <label>57.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McCann</surname><given-names>LC</given-names></string-name>, <string-name><surname>Tomlinson</surname><given-names>A</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>EI</given-names></string-name>, <string-name><surname>Papa</surname><given-names>V.</given-names></string-name></person-group><article-title>Effectiveness of artificial tears in the management of evaporative dry eye</article-title>. <source><italic toggle="yes">Cornea</italic></source><italic toggle="yes">.</italic><year>2012</year>; <volume>31</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">21968605</pub-id></mixed-citation>
              </ref>
              <ref id="bib58">
                <label>58.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abraha</surname><given-names>I</given-names></string-name>, <string-name><surname>Montedori</surname><given-names>A.</given-names></string-name></person-group><article-title>Modified intention to treat reporting in randomised controlled trials: systematic review</article-title>. <source><italic toggle="yes">BMJ</italic></source><italic toggle="yes">.</italic><year>2010</year>; <volume>340</volume>: <fpage>c2697</fpage>.<pub-id pub-id-type="pmid">20547685</pub-id></mixed-citation>
              </ref>
              <ref id="bib59">
                <label>59.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Prinz</surname><given-names>J</given-names></string-name>, <string-name><surname>Maffulli</surname><given-names>N</given-names></string-name>, <string-name><surname>Fuest</surname><given-names>M</given-names></string-name>, <string-name><surname>Walter</surname><given-names>P</given-names></string-name>, <string-name><surname>Hildebrand</surname><given-names>F</given-names></string-name>, <string-name><surname>Migliorini</surname><given-names>F.</given-names></string-name></person-group><article-title>Placebo administration for dry eye disease: a level I evidence based systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Int J Clin Pharm</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>44</volume>: <fpage>1087</fpage>–<lpage>1101</lpage>.<pub-id pub-id-type="pmid">35939178</pub-id></mixed-citation>
              </ref>
              <ref id="bib60">
                <label>60.</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herzog</surname><given-names>E</given-names></string-name>, <string-name><surname>Keller</surname><given-names>I</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>S</given-names></string-name>, <string-name><surname>Zinkernagel</surname><given-names>MS</given-names></string-name>, <string-name><surname>Zysset-Burri</surname><given-names>DC.</given-names></string-name></person-group><article-title>Challenges in the characterization of the ocular surface microbiome</article-title>. <source><italic toggle="yes">Invest Ophthalmol Vis Sci</italic></source><italic toggle="yes">.</italic><year>2022</year>; <volume>63</volume>(<issue>7</issue>): <fpage>1682–A0512–1682–A0512</fpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
